Philip H. Coelho, President and CEO of Synergenesis, Inc., is an engineer and inventor, educated at the University of California, Davis, where he specialized in thermodynamics and machine design. He has been awarded more than 30 U.S. patents related to cell cryopreservation, cryogenic robotics, cell selection, blood protein harvesting and surgical hemostasis. During his tenure as Founder, Chairman and CEO of ThermoGenesis Corp., Mr. Coelho developed the BioArchive robotic system for controlled-rate freezing and cryogenically archiving units of hematopoietic stem and progenitor cells (HSPCs) derived from placental/cord blood and the AutoXpress System, which automates the sterile harvesting of HSPCs from cord blood into a 25 ml dual-compartment freezing bag. The BioArchive and AutoXpress Systems have defined Good Manufacturing Practice standards in cord blood processing and banking worldwide. As CEO of Synergenesis, Inc., Mr. Coelho is leading the development of six new products that improve the speed and efficiency of the isolation and capture of purified stem and progenitor cells resident within peripheral or placental/cord blood, bone marrow or adipose tissue. Mr. Coelho has been a member of the Catalyst board of directors since October 2002.